Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Nature Communications|December 22, 2018
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type INerea Zabaleta, Miren Barberia, Cristina Martin-Higueras, et al.
Kidney International Reports|February 5, 2024
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1Cristina Martin-Higueras, Lodovica Borghese, Armando Torres, et al.
Journal of Asthma and Allergy|March 1, 2022
COVID-19 Course in Allergic Asthma Patients: A Spanish Cohort AnalysisAlicia Habernau Mena, Ismael García-Moguel, María Vazquez de la Torre Gaspar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 27, 2024
BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injuryMaria Laura Saiz, Laura Lozano-Chamizo, Aida Bernardo Florez, et al.
Kidney International Reports|October 21, 2024
Intrafamilial Disease Heterogeneity in Primary Hyperoxaluria Type 1Lisa J Deesker, Hazal A Karacoban, Elisabeth L Metry, et al.
Cell Reports|October 24, 2019
Signal Integration and Transcriptional Regulation of the Inflammatory Response Mediated by the GM-/M-CSF Signaling Axis in Human MonocytesRamon M Rodriguez, Beatriz Suarez-Alvarez, Jose L Lavín, et al.
Plos Genetics|June 9, 2017
Hybridization and polyploidy enable genomic plasticity without sex in the most devastating plant-parasitic nematodesRomain Blanc-Mathieu, Laetitia Perfus-Barbeoch, Jean-Marc Aury, et al.
Science (New York, N.Y.)|July 27, 2019
Thermal unequilibrium of strained black CsPbI3 thin filmsJulian A Steele, Handong Jin, Iurii Dovgaliuk, et al.
Pageof 16